Cera Sanitaryware reported a 19.5% year-on-year increase in standalone revenue from operations for the quarter ended June 30, 2026, reaching ₹486 crore. Despite robust top-line growth driven by volume-led expansion in sanitaryware and faucetware segments, standalone net profit declined marginally to ₹453 crore from ₹465 crore in the corresponding period of FY26. The divergence was primarily caused by a 7.3% contraction in EBITDA to ₹705 crore, reflecting persistent margin pressures from elevated input costs that outweighed operational efficiencies.

The Board of Directors, meeting on August 7, 2026, approved the unaudited financial results which were reviewed by the Audit Committee and subjected to a limited review by Statutory Auditors Singhi & Co. The results were prepared in accordance with Ind AS and Regulation 33 of the SEBI (LODR) Regulations, 2015. Chairman & Managing Director Vikram Somany attributed the revenue growth to strong performance in the retail channel and project business, noting that the company continues to gain market share despite an evolving industry landscape.

Standalone Financial Performance

Revenue from operations rose to ₹4,860 million (₹486 crore) in Q1FY27, up from ₹4,068 million (₹406.8 crore) in Q1FY26. The sanitaryware segment, contributing 47% of overall revenues, grew by 14.1%, while the faucetware segment, accounting for 40% of revenues, surged by 25.3%. Other income also saw a modest increase to ₹21.29 crore from ₹18.60 crore. However, total expenses grew at a faster pace, rising to ₹447.46 crore from ₹364.27 crore, driven primarily by higher employee benefits expense and purchases of stock-in-trade.

Note: EBITDA for Q1FY26 derived from reported growth rate and Q1FY27 figure.

Margin Dynamics and Operational Costs

The operating environment remained characterized by elevated input costs during the quarter. While Cera Sanitaryware remains relatively better positioned than several industry participants owing to its established sourcing arrangements and strong in-house manufacturing capabilities, calibrated pricing actions were necessary to preserve margin resilience. Employee benefits expense increased significantly to ₹78.37 crore from ₹64.52 crore. Finance costs remained low at ₹1.27 crore. The working capital cycle improved by around 25 days year-on-year, primarily on the back of a reduction in inventory days.

Key Developments and Disclosures

• Labour Code Adjustments: In FY26, the company had recognized an exceptional provision of ₹18.46 crore for past service costs related to gratuity and leave benefits under the New Labour Codes. This was subsequently reassessed, leading to a reversal of ₹10.65 crore in Q4FY26 as exceptional items. The company continues to monitor finalization of Central/State Rules.
• ESOP Exercise: During Q1FY27, the ESOP Trust transferred 2,011 equity shares upon exercise of stock options under ESOS 2024.
• Dividend: A dividend of ₹75 per equity share for FY26 was approved by shareholders in the AGM held on July 23, 2026.
• Brand Campaign: The company launched "Your Moment of CERA", a new national brand campaign featuring Kriti Sanon, reinforcing its premium positioning.

What the Numbers Show

While consolidated results showed mixed signals with EBITDA margin contracting to 10.13% from 13.1% in the prior year, the standalone figures reveal that core operational profitability remains relatively stable despite cost pressures. The 19.5% revenue growth outpaces the 2.6% decline in net profit, suggesting that volume growth is partially offsetting margin erosion. Management maintains its outlook of revenue growth of 18–20% and EBITDA margin in the range of 13.5%–14% for FY27, supported by ongoing faucetware capacity expansion expected to be completed during the fiscal year.

Cera Sanitaryware Limited Cera Sanitaryware will host an in-person group meeting with analysts and institutional investors on August 13, 2026. The engagement is part of the Equirus Annual India Conference scheduled to be held in Mumbai. This interaction provides market participants with an opportunity to discuss the company’s strategic outlook and operational performance directly with management.

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Cera Sanitaryware submitted the intimation to both the Bombay Stock Exchange (BSE) and the National Stock Exchange of India Limited (NSE) on August 6, 2026.

Meeting Details

The company has outlined the specific parameters of the investor event in its regulatory filing. The meeting is classified as a group session, ensuring that information is shared equally among all participating investors.

Compliance and Disclosures

Hemal Sadiwala, Company Secretary of Cera Sanitaryware, signed the disclosure letter dated August 6, 2026. The company emphasized that the schedule is tentative and subject to change based on exigencies from either the investors or the company.

Crucially, Cera Sanitaryware stated that no unpublished price-sensitive information (UPSI) is proposed to be shared during this group meeting. This assurance aligns with standard compliance protocols to prevent insider trading violations during public investor interactions.

What the Numbers Show

While no financial metrics were disclosed in this specific filing, the decision to participate in a major industry conference like the Equirus Annual India Conference signals active engagement with the investment community. Such meetings are typically used to reinforce investor confidence and clarify strategic directions ahead of quarterly earnings releases.